Genetic variants in Ras/Raf/MEK/ERK pathway are associated with gastric cancer risk in Chinese Han population

被引:6
|
作者
Wang, Xiaowei [1 ,2 ]
Wu, Xu [3 ]
Xin, Junyi [1 ,2 ]
Li, Shuwei [1 ,2 ]
Zheng, Rui [1 ,2 ]
Guan, Dan [1 ,2 ]
Gong, Weida [4 ]
Zhao, Qinghong [5 ]
Wang, Meilin [1 ,2 ,6 ]
Chu, Haiyan [1 ,2 ]
Du, Mulong [1 ,7 ]
Tao, Guoquan [3 ]
Zhang, Haiyan [8 ]
Zhang, Zhengdong [1 ,2 ,6 ]
机构
[1] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Environm Genom, Nanjing, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Genet Toxicol,Key Lab Modern Toxicol,Minist, Nanjing, Peoples R China
[3] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Gen Surg, Huaian, Peoples R China
[4] Yixing Canc Hosp, Dept Gen Surg, Yixing, Peoples R China
[5] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Peoples R China
[6] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Environm Genom, 101 Longmian Ave, Nanjing 211166, Peoples R China
[7] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Biostat, 101 Longmian Ave, Nanjing 211166, Peoples R China
[8] Nanjing Med Univ, Xuzhou Clin Coll, Xuzhou Cent Hosp, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Gastric cancer; Ras; Raf; MEK; ERK pathway; SNP; Susceptibility; SUSCEPTIBILITY LOCI; WIDE ASSOCIATION;
D O I
10.1007/s00204-020-02771-w
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The dysregulation of Ras/Raf/MEK/ERK pathway governs occurrence and progression of cancers. In previous studies, genome-wide association studies (GWAS) have identified multiple gene loci related to gastric cancer. However, a great many genetic loci have been missed due to multiple statistical comparisons of GWAS. In this study, Multi-marker Analysis of GenoMic Annotation (MAGMA) was applied to analyze genes in Ras/Raf/MEK/ERK pathway and their single nucleotide polymorphisms (SNPs) based on Chinese GWAS including 1625 gastric cancer cases and 2100 controls. The SNP effects on gastric cancer susceptibility were calculated on the basis of a logistic regression model. Expression quantitative trait loci (eQTL) analysis was performed based on the genotype-tissue expression (GTEx) project. We identified that three SNPs inMAP2K1, rs4287513, rs76906202 and rs11631448 were markedly associated with gastric cancer risk (rs4287513: OR = 1.30, 95% CI = 1.10-1.54,P = 1.92 x 10(-3); rs76906202: OR = 0.87, 95% CI = 0.79-0.96,P = 3.72 x 10(-3); rs11631448: OR = 1.21, 95% CI = 1.05-1.39,P = 6.74 x 10(-3)). All the loci were eQTLs forMAP2K1in normal gastric samples. Moreover, the low expression ofMAP2K1was significantly associated with poor survival in gastric cancer patients. Thus,MAP2K1might represent a key gene related to gastric cancer in Ras/Raf/MEK/ERK pathway, whereas SNPs inMAP2K1confer gastric cancer susceptibility by having biological effects on theMAP2K1expression.
引用
收藏
页码:2683 / 2690
页数:8
相关论文
共 50 条
  • [41] Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma
    Favre, Gilles
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 321 - 336
  • [42] Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population
    Wu, Guo-cong
    Zhang, Zhong-tao
    MEDICAL ONCOLOGY, 2015, 32 (01)
  • [43] Parallel targeting of RAF/MEK/ERK pathway in RAS-mutant embryonal rhabdomyosarcoma
    Vaseva, Angelina V.
    Bandyopadhyay, Abhik
    Del Pozo, Vanessa
    Goodwin, Craig M.
    Gautam, Prson
    Wennerberg, Krister
    Wood, Kris C.
    Chen, Yidong
    Der, Channing J.
    Houghton, Peter J.
    CANCER RESEARCH, 2020, 80 (14) : 72 - 72
  • [44] Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management
    Manousaridis, I.
    Mavridou, S.
    Goerdt, S.
    Leverkus, M.
    Utikal, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (01) : 11 - 18
  • [45] Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review)
    Chang, FM
    Steelman, LS
    Shelton, JG
    Lee, JT
    Navolanic, PM
    Blalock, WL
    Franklin, R
    McCubrey, JA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (03) : 469 - 480
  • [46] The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
    Li, Lei
    Zhao, Guo-Dong
    Shi, Zhe
    Qi, Li-Li
    Zhou, Li-Yuan
    Fu, Ze-Xian
    ONCOLOGY LETTERS, 2016, 12 (05) : 3045 - 3050
  • [47] Prohibitins Role in Cellular Survival Through Ras-Raf-MEK-Erk Pathway
    Chowdhury, Indrajit
    Thompson, Winston E.
    Thomas, Kelwyn
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (08) : 998 - 1004
  • [48] Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
    Stefania Merighi
    Annalisa Benini
    Prisco Mirandola
    Stefania Gessi
    Katia Varani
    Edward Leung
    Stephen MacLennan
    Pier Giovanni Baraldi
    Pier Andrea Borea
    Purinergic Signalling, 2006, 2 (4) : 627 - 632
  • [49] Several genetic variants associated with systemic sclerosis in a Chinese Han population
    Liu, Chenxi
    Yan, Songxin
    Chen, Haizhen
    Wu, Ziyan
    Li, Liubing
    Li, Yongzhe
    CLINICAL RHEUMATOLOGY, 2023, 42 (03) : 773 - 781
  • [50] Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
    Meryem Jafari
    Abdelilah Laraqui
    Walid Baba
    Soukaina Benmokhtar
    Sara El Zaitouni
    Abdelmounaim Ait Ali
    Ahmed Bounaim
    Mountassir Moujahid
    Rachid Tanz
    Tarik Mahfoud
    Yassir Sbitti
    Hicham El Annaz
    Rachid Abi
    Mohamed Rida Tagajdid
    Safae El Kochri
    Idriss Amine Lahlou
    Houda El Hsaini
    Lamiae Belayachi
    Abdelaziz Benjouad
    Mohammed Ichou
    Amina En-Nya
    Khalid Ennibi
    BMC Cancer, 22